Results 271 to 280 of about 118,445 (283)
Some of the next articles are maybe not open access.
Presentation of bacterial lipid antigens by CD1 molecules
Trends in Microbiology, 1998Human CD1 molecules bind and display or present lipid and glycolipid antigens from mycobacteria for recognition by T cells. Presentation requires uptake of antigen into endosomes, where it binds to CD1. T-cell recognition of CD1-presented nonpeptide antigens is a newly defined immune response that could be important for host defense against a variety ...
T I, Prigozy, M, Kronenberg
openaire +2 more sources
Cationic supported lipid bilayers for antigen presentation
International Journal of Pharmaceutics, 2007Polystyrene sulfate (PSS) particles (301 nm mean diameter) were covered with single cationic dioctadecyldimethylammonium bromide (DDA) bilayers and used for antigen adsorption and presentation. The antigen was a mixture of purified 18/14 Taenia crassiceps proteins (18/14-Tcra).
N, Lincopan +3 more
openaire +2 more sources
The cellular and biochemical rules of lipid antigen presentation
European Journal of Immunology, 2009AbstractThe recognition of both protein and lipid antigens follows similar strategies that rely on different molecular mechanisms. APC present lipid antigens exploiting the same mechanisms implicated in lipid translocation, lipoprotein assembly and lipid degradation. An important issue is how the lipid structure contributes to antigenicity.
De Libero, Gennaro +2 more
openaire +4 more sources
Antigenicity of Lipid-Adsorbed Diphtheria and Tetanus Toxoids
The Journal of Immunology, 1964Summary Studies of the effectiveness of hexadecylamine (HDA)-adsorbed vaccines have been extended to bacterial as well as viral antigens. Adsorption experiments show that diphtheria and tetanus toxoids adsorb to HDA with great efficiency whereas about 30 to 40% of the protein, which is not toxoid, does not adsorb.
J S, YOUNGNER, V, AXELROD
openaire +2 more sources
Lipid-Protamine-DNA-Mediated Antigen Delivery
Current Drug Delivery, 2005The development of novel 'new generation' vaccine systems that is based on proteins, peptides or DNA is of great current interest. However, due to the lower efficiencies of these new generation vaccines, they are seldomly used alone. Rather, their formulations often contain adjuvants, either to enhance the immune responses or to reduce dosing.
Dileep Padinjarae, Vangasseri +2 more
openaire +2 more sources
Murine IgG subclass antibodies to antigens incorporated in liposomes containing lipid A
Immunology Letters, 1995Mangala Rao +2 more
exaly